Disparity in initiation of checkpoint inhibitors among commercially insured and Medicare Advantage patients with metastatic melanoma

Meng Li, Kaiping Liao, Malgorzata Nowakowska, Mackenzie Wehner, Ya Chen Tina Shih

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Disparity in initiation of checkpoint inhibitors among commercially insured and Medicare Advantage patients with metastatic melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences

Chemistry